A case of failure to thrive secondary to primary hyperoxaluria type 1.

Radiol Case Rep 2020 Oct 5;15(10):1806-1808. Epub 2020 Aug 5.

Department of Radiology, Jacobi Medical Center, 1400 Pelham Parkway, Bronx, NY 10461, USA.

Primary hyperoxaluria type 1 is a rare genetic condition characterized by oxalate deposition in the kidneys. We report findings of an 8-month old female presenting with failure to thrive, poor oral intake, and kidney stones resulting in the diagnosis of primary hyperoxaluria type 1. The patient exhibits a unique presentation without renal failure at the time of diagnosis suggesting a previously unreported comorbidity in early stages of disease.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radcr.2020.07.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413989PMC
October 2020
Save 15% Survey

Similar Publications

QJM: An International Journal of MedicineTitle: "Imaging of Primary hyperoxaluria with classical renal and skeletal changes".

QJM 2021 Feb 8. Epub 2021 Feb 8.

Primary hyperoxaluria (PH) is a rare metabolic disorder with autosomal recessive inheritance pattern which is due to deficiency of alanine-glyoxylate aminotransferase enzyme. It causes defective glyoxylate metabolism in liver which in turn leads to excessive oxalate production and deposition. Supersaturation of oxalic acid in urine (>45 mg/day) is known as hyperoxaluria which causes nephrolithiasis, cortical nephrocalcinosis and renal insufficiency. Read More

View Article and Full-Text PDF
February 2021

Clinical and Metabolic Correlates of Pure Stone Subtypes.

J Endourol 2021 Feb 11. Epub 2021 Feb 11.

Indiana University School of Medicine, 12250, Urology, 1801 Senate Blvd. #220, Indianapolis, Indiana, United States, 46202;

: There are multiple stone types, each forming under different urinary conditions. We compared clinical and metabolic findings in pure stone formers to understand if there are consistent factors that differentiate these groups in terms of underlying etiology and potential for empiric treatment. : Pure SFs based on infrared spectroscopic analysis of stones obtained at our institution between 01/2002 and 07/2018 with a corresponding 24-hour urinalysis were retrospectively evaluated. Read More

View Article and Full-Text PDF
February 2021

Is stiripentol truly effective for treating primary hyperoxaluria?

Clin Kidney J 2021 Jan 25;14(1):442-444. Epub 2020 May 25.

Department of Pediatrics, Division of Pediatric Nephrology, University Children's Hospital of the Rheinische Friedrich-Wilhelms-University, Bonn, Germany.

View Article and Full-Text PDF
January 2021

Calciphylaxis or vascular oxalosis?

Clin Kidney J 2021 Jan 18;14(1):435-438. Epub 2020 Jan 18.

Division of Nephrology, Indiana University School of Medicine, Indianapolis, IN, USA.

We report the case of a 31-year-old female with primary hyperoxaluria type 1 with end-stage kidney disease who developed severe peripheral vascular disease leading to limb amputation initially thought to be secondary to calciphylaxis. However, polarized review of the pathologic specimen revealed calcium oxalate deposition in the lumen of blood vessels. This unusual presentation of systemic oxalosis demonstrates the adverse consequences of elevations of serum oxalate in patients with hyperoxaluria and that levels can acutely worsen with abrupt onset of kidney failure. Read More

View Article and Full-Text PDF
January 2021